Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Xanthus Pharmaceuticals logo — Innovative treatments for cancer and autoimmune disorders th...

Xanthus Pharmaceuticals

Innovative treatments for cancer and autoimmune disorders through pioneering small-molecule therapeutics.

Founded 2001 Series B Total: $76.20M Biopharma, Biotechnology +1

General Information

Company Name Xanthus Pharmaceuticals
Founded Year 2001
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series B
Social

Get notified when Xanthus Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Xanthus Pharmaceuticals

Xanthus Pharmaceuticals is a biopharmaceutical company founded in 2001 with a focus on discovering, developing, and commercializing small-molecule therapeutics for cancer and autoimmune disorders. The company's slogan reflects its dedication to pioneering innovative treatments for these challenging health conditions. Xanthus recently received a significant $25.00M Series B investment on 01 December 2006, with the funding coming from a diverse group of investors including HealthCare Ventures, GIMV, NeoMed Management, Kester Capital, Hambrecht & Quist Capital Management, The Still River Fund, GeneChem, CDIB BioScience Ventures, Yasuda Enterprise Development, and CDP Capital Technology Ventures. With this injection of funding, Xanthus Pharmaceuticals is well-positioned to continue its advancements in the biopharma, biotechnology, and pharmaceutical industries, furthering its mission to revolutionize treatment options for cancer and autoimmune disorders.

Taxonomy: Biopharmaceutical, Cancer treatment, Autoimmune disorders, Small-molecule therapeutics, Drug discovery, Drug development, Acquisition, Commercialization

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 10
Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Dec 2006
Series B •••••• - 12 Dec 2003
Series A •••••• - 05 Feb 2003

Xanthus Pharmaceuticals Alternatives & Competitors

Xanthus Pharmaceuticals vs
Congruence Medical Solutions
Congruence Medical Solutions United States

Addressing compelling needs in injectable drug delivery

8 employees
Xanthus Pharmaceuticals vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
Xanthus Pharmaceuticals vs
National Drug Screening, Inc.
National Drug Screening, Inc. United States

Drug and alcohol testing programs for large and small employers.

21 employees
Biotechnology, Health Care

FAQ About Xanthus Pharmaceuticals

Innovative treatments for cancer and autoimmune disorders through pioneering small-molecule therapeutics.
Xanthus Pharmaceuticals was founded in 2001.
Xanthus Pharmaceuticals operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Xanthus Pharmaceuticals has completed 3 funding rounds, raising a total of $76.20M. The latest funding stage is Series B.
Top alternatives and competitors to Xanthus Pharmaceuticals include Congruence Medical Solutions, Bostal Drug Delivery, National Drug Screening, Inc., Forensic Fluids Laboratories, MPR - Medical Professionals Reference. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xanthus Pharmaceuticals and Congruence Medical Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Xanthus Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy